Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Opiranserin on catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor
KCT0011555Phase 4Not yet recruiting
- Sponsor
- Vivozon
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of opiranserin in bladder cancer, sponsored by Vivozon. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
opiranserin
03
Conditions
bladder cancer
Beyond the preview
Go deeper on KCT0011555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011555.